The CTMR was Renewed!
We are thrilled to share that the CTMR was RENEWED! Here’s to another 5 years of supporting muscle research translational muscle research!
Similar Posts
Congratulations to Jeff Chamberlain for receiving the MDA Legacy Award
Congratulations to CTMR faculty member Jeff Chamberlain for receipt of the 2024 Muscular Dystrophy Association (MDA) Legacy Award for Achievement in Research. Jeff is a leading investigator in gene therapy for Duchenne muscular dystrophy (DMD). This award is presented for outstanding contributions to translational neuromuscular disease research and will be presented at the 2024 MDA…
CTMR is Transitioning to Bluesky
The CTMR is transitioning from X (Twitter) to Bluesky. Follow us on Bluesky Our X (Twitter) account will be closed at the end of January.
Engineering heart health- featuring CTMR investigators
The remarkable research of CTMR faculty was recently featured on the UW College of Engineering homepage! Read the full story here: Engineering heart health. Congratulations to the Sniadecki, Davis, and Regnier research groups!
CTMR Faculty- Valerie Daggett- to Present the UW University Faculty Lecture
Congratulations to CTMR investigator Dr. Valerie Daggett for being awarded the UW 2023 University Faculty Lecture award! Dr. Daggett will present her work at the 47th annual University Faculty Lecture. Valerie Daggett, PhD David and Nancy Auth Endowed Professor in the Department of Bioengineering Talk Title: Revolutionary: The Quest to Detect and Cure Alzheimer’s Monday,…
New CTMR Program Manager
The CTMR’s Program Manager, Katie Dickinson, is transitioning to support other programs at UW. We will miss Katie in the CTMR. A big thank you to her for skillfully supporting the CTMR over the past year. We wish her all the best in her future endeavors! We are excited to introduce our new Program Manager…
Complex problems require collaborative science
CTMR Investigators, Mike Regnier and David Mack, were part of a multi-institutional research effort to uncover the disease mechanism for hypertrophic cardiomyopathy caused by a mutation in myosin (MYH7 G256E). The project was a collaborative effort between investigators at UW, Stanford University, University of California Santa Barbara, the Curie Institute in Paris, and the Allen Institute for Cell…
